As well, melatonin treatment effectively potentiated the hypoglycemic effects of hUC-MSCs in T2D model via potent PI3K/AKT-amelioration of IR and regulation of hepatic glucose metabolism. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.